AUG 14, 2018 9:01 PM PDT

Anticancer Drugs Help Plants Fight Infection

WRITTEN BY: Nouran Amin

Image Retrieved From Unsplash, www.unsplash.com

Drugs used for cancer treatments may now help plants fight diseases. A study conducted at Washington State University (WSU), by two plant pathologists—Lee Hadwiger and Kiwamu Tanaka, has revealed that cancer-fighting drugs used on humans can help scientists examine particular biochemical pathways that will allow plants to battle infections. The study was published in the journal Frontiers in Plant Science.

The WSU Department of Plant Pathology specifically studied anticancer drugs that hold the ability to alter the DNA of cancerous cells, when used in high concentrations, in order to slow their growth or completely inhibit it. However, when these anticancer drugs were used in low concentrations in plants, they were found to change the plant cell’s DNA by turning on genes needed for defense against pathogenic invasion. These studied anticancer drugs were DNA-specific and included actinomycin D, which is also known as ‘dactinomycin’ to the pea plant (Pisum sativum).

Image Retrieved From Unsplash, www.unsplash.com

When these drugs were administered on plants, they excreted increased levels of an antimicrobial-based substance known as pisatin; a marker for a plants defense system. The treated plants were then exposed by scientists to fungal infections where the infection stopped within hours. Although Hadwiger and Tanaka, do not predict that anticancer medications will be used on crops, they do believe that this discovery brought deeper understanding onto the interactions between chemicals and plant DNA. "We used these drugs as a tool to understand how plants defend themselves from pathogens," explains Hadwiger. "We now understand how these defense genes can be activated and are using that knowledge to develop disease resistance against fungal infections and other pathogens. We needed a tool to stop the growth process in the plants and knew actinomycin D did that," Hadwiger said. "We thought we did something wrong because it didn't work at all."

Image via Phys.Org: "The effect of different concentrations of actinomycin D applied to pea tissue. The top image is lower concentration of the drug, the bottom the highest concentration." Image Credit: WSU  

 

However, when the researchers decided to administer actinomycin D on the pea plant using low concentrations, instead of the usual dose for cancer treatments, the plant was able to fight infections. "We finally figured out what was going on with the different reactions based on high and low concentrations," Hadwiger said. Since plant and animal genes are activated in the same way, it was natural to think that drugs would exert the same actions. But, researchers later found out that plant physiology handles drugs differently than in animals and humans. DNA does not readily recognize a drug as anticancer, it is just a set of compounds that is capable of alerting its makeup. "Cells only recognize the chemistry shot at them," Hadwiger explains. "We didn't expect anticancer drugs to help plants fight pathogens. But once we understood the interaction, it made sense."

The researchers of the study do not expect anyone to use anticancer medications on their crops, however, the research nonetheless is insightful. “In basic research, when you actually understand the workings or mechanisms of something, you'll be able to apply it to real-world use," Tanaka said. "We think this will have important impacts for growers that will help better fight pathogens in the near future."

 

Source: Washington State University

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
OCT 09, 2020
Technology
Deep Learning Advances Drug Design
OCT 09, 2020
Deep Learning Advances Drug Design
Computational data is advancing all areas of medicine and pharmaceutical drug development is certainly no exception. &nb ...
OCT 10, 2020
Drug Discovery & Development
Fishnet of Nanoparticles Traps Drug Molecules
OCT 10, 2020
Fishnet of Nanoparticles Traps Drug Molecules
‘Fishnet’ Nanoparticles Traps Drug Molecules A team at Northwestern University have casted a net of nanopart ...
OCT 11, 2020
Drug Discovery & Development
Treating Connective Tissue Disorders
OCT 11, 2020
Treating Connective Tissue Disorders
Collaborative research efforts are geared to improving disease that affects connective tissues via innovative drug deliv ...
NOV 02, 2020
Drug Discovery & Development
Type 2 Diabetic Drug Combo Proves Effective
NOV 02, 2020
Type 2 Diabetic Drug Combo Proves Effective
A common first-line therapeutic for type 2 diabetes is the metformin drug used to stabilize blood glucose levels. Althou ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
Loading Comments...